FDA OKs Immune Globulin Cuvitru for Primary Immunodeficiency FDA OKs Immune Globulin Cuvitru for Primary Immunodeficiency

Approval of immune globulin subcutaneous 20% solution follows positive data on efficacy and safety, as well as infusion time and number of injections sites.FDA Approvals
Source: Medscape Allergy Headlines - Category: Allergy & Immunology Tags: Allergy & Clinical Immunology News Alert Source Type: news